Prognostic Stage IV Breast Cancer AJCC v8 Withdrawn Phase 1 Trials for Fulvestrant (DB00947)

IndicationStatusPhase
DBCOND0109667 (Prognostic Stage IV Breast Cancer AJCC v8)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04498520Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic CancerTreatment